Want to join the conversation?
On Jan. 8, 2016, $MYL entered into an agreement with Momenta Pharmaceuticals to develop, manufacture & commercialize up to 6 of Momenta's current biosimilar candidates. $MYL paid an up-front cash payment of $45MM to Momenta. The company & Momenta will jointly be responsible for product development and will equally share product costs and profits.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.